Clinical Trials · NCT05340868
Genetics of the Acute Response to Oral Semaglutide
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Medical University of Bialystok
- Enrollment
- 1,000
- Start date
- Sep 2022
- Locations
- 1 site, Poland
- Primary endpoint
- Glycemic measures - change in HbA1c (%)